Atika Capital Management’s Celgene Corp CELG Stock Holding History

Atika Capital Management’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-3,000	Closed	-$359K	–	76
2015 Q4	$359K	Buy	+3,000	New	+$347K	0.18%	53
2015 Q2	–	Sell	-15,500	Closed	-$1.77M	–	84
2015 Q1	$1.79M	Sell	15,500 -6,000	-28%	-$717K	1.19%	40
2014 Q4	$2.4M	Sell	21,500 -11,500	-35%	-$1.21M	1.76%	18
2014 Q3	$3.13M	Buy	+33,000	New	+$2.98M	2.4%	13

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Atika Capital Management's CELG Position: Q1 2016 in Review

Atika Capital Management sold out of Celgene Corp (CELG) in Q1 2016, closing a stake of 3,000 shares — an estimated $359K sold.

Atika Capital Management first reported a position in CELG in Q3 2014 and held it in 4 quarters. The position peaked at $3.13M in Q3 2014. 1,224 funds tracked by Wall St. Rank hold CELG as of Q1 2016.

Atika Capital Management reported no remaining Celgene Corp position as of Q1 2016 after selling out during the quarter.
Atika Capital Management sold 3,000 Celgene Corp shares in Q1 2016, an estimated $359K.
Atika Capital Management first reported a position in Celgene Corp in Q3 2014 and held it in 4 quarters.
Atika Capital Management's Celgene Corp position peaked at $3.13M in Q3 2014.
1,224 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2016.

Based on Atika Capital Management's 13F filing for Q1 2016, filed 16 May 2016.